A highly sensitive fluorescent aptasensor for detection of prostate specific antigen based on the integration of a DNA structure and CRISPR-Cas12a

Anal Chim Acta. 2022 Aug 1:1219:340031. doi: 10.1016/j.aca.2022.340031. Epub 2022 Jun 3.

Abstract

Herein, a facile fluorescent CRISPR-Cas12a-based sensing strategy is presented for prostate specific antigen (PSA), as a prostate cancer biomarker, with the assistance of a cruciform DNA nanostructure and PicoGreen (PG) as a fluorochrome. Highly sensitive recognition of PSA is one of the virtues of the proposed method which comes from the use of unique features of both CRISPR-Cas12a and DNA structure in the design of the aptasensor. The presence of PSA creates a cruciform DNA nanostructure in the sample which can be loaded by PG and make sharp fluorescence emission. While, when there is no PSA, the CRISPR-Cas12a digests sequences 1 and 3 as single-stranded DNAs, causing no DNA structure and a negligible fluorescence is detected after addition of PG. This aptasensor presents a sensitive recognition performance with detection limit of 4 pg/mL and a practical use for determination of PSA in serum samples. So, this analytical strategy introduces a convenient and highly sensitive approach for detection of disease biomarkers.

Keywords: Cas12a-crRNA; Cruciform DNA structure; Fluorescent method; Highly sensitive detection; PSA; Serum.

MeSH terms

  • Biosensing Techniques* / methods
  • CRISPR-Cas Systems
  • DNA / genetics
  • DNA, Cruciform
  • Humans
  • Male
  • Prostate-Specific Antigen*

Substances

  • DNA, Cruciform
  • DNA
  • Prostate-Specific Antigen